Screener
Mineralys Therapeutics, Inc. MLYS Other Non-Current Assets
Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Mineralys Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: Mineralys Therapeutics, Inc.’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 5:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001933414-26-000084
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Prepaid and other current assets | 6,410 | 4,751 |
| Total current assets | 652,470 | 661,386 |
| Property and equipment, net | 32 | 38 |
| Other assets | 360 | 382 |
| Total assets | $652,862 | $661,806 |
| Liabilities and stockholders’ equity | ||
| Current liabilities: | ||
| Accounts payable | $1,116 | $2,017 |
Item 1. Financial Statements
FAQ
- What is Mineralys Therapeutics, Inc.'s other non-current assets?
- Mineralys Therapeutics, Inc. (MLYS) reported other non-current assets of $360K in Q1 2026.
- How has Mineralys Therapeutics, Inc.'s other non-current assets changed year-over-year?
- Mineralys Therapeutics, Inc.'s other non-current assets decreased by 9.3% year-over-year, from $397K to $360K.
- What is the long-term trend for Mineralys Therapeutics, Inc.'s other non-current assets?
- Over 3 years (2022 to 2025), Mineralys Therapeutics, Inc.'s other non-current assets has grown at a -38.4% compound annual growth rate (CAGR), from $1.63M to $382K.
- What does other non-current assets mean?
- Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.
Ask your AI about Mineralys Therapeutics, Inc.'s other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude